FB
AZN icon

Finward Bancorp’s AstraZeneca AZN Stock Holding History

Finward Bancorp’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$294K Hold
1,548
– – 0.22% 84
2026
Q1 		$305K Sell
1,548
-1
-0.1% -$193 0.24% 81
2025
Q4 		$285K Hold
1,549
– – 0.22% 83
2025
Q3 		$238K Hold
1,549
– – 0.18% 97
2025
Q2 		$216K Hold
1,549
– – 0.17% 95
2025
Q1 		$228K Buy
+1,549
New +$224K 0.2% 93

Other funds holding AZN

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
CAM
Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return
MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
SAM
Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return

Finward Bancorp's AZN Position: Q2 2026 in Review

Finward Bancorp held its AstraZeneca (AZN) position steady in Q2 2026 at 1,548 shares worth $294K. The position accounts for 0.22% of the portfolio, ranked #84.

Finward Bancorp first reported a position in AZN in Q1 2025 and has held it in 6 quarters since. The position peaked at $305K in Q1 2026. 316 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Finward Bancorp held 1,548 shares of AstraZeneca worth $294K as of Q2 2026.
  • Finward Bancorp left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.22% of Finward Bancorp's portfolio in Q2 2026, its #84 holding.
  • Finward Bancorp first reported a position in AstraZeneca in Q1 2025 and has held it in 6 quarters since.
  • Finward Bancorp's AstraZeneca position peaked at $305K in Q1 2026.
  • 316 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Finward Bancorp's 13F filing for Q2 2026, filed 16 Jul 2026.